News | May 27, 2022
Torrent Pharma acquires four brands from Dr Reddy’s
The integration and transition of the brands are expected to be completed by June 2022.
The integration and transition of the brands are expected to be completed by June 2022.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
DCGI approved the drug based on the review of clinical data
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The agreement will help ensure wider reach and access to patients in India
A PhD in Pharmaceutical Sciences, Dr Singh has led global regulatory audits, product validations, and quality systems spanning therapeutic formulations, dietary supplements, and functional foods
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
Subscribe To Our Newsletter & Stay Updated
